|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR |
1 Ciber Enfermedades Respiratorias, Departamento de Bioquímica y Biología Moleculary Fisiología/Instituto de Biologíay Genética Molecular, Universidad de Valladolid/Consejo Superior de Investigaciones Científicas, Facultad de Medicina, 47005 Valladolid, Spain
2
Department of Pharmacology, Faculty of Medical Sciences, New University of Lisbon, 1169-056 Lisbon, Portugal
| Abstract |
|---|
|
|
|---|
(Received 31 August 2007;
accepted after revision 15 October 2007;
first published online 18 October 2007)
Corresponding author C. Gonzalez: Departamento de Bioquímica y, Biología Molecular y Fisiología, Facultad de Medicina. Universidad de Valladolid, 47005 Valladolid. Spain. Email: constanc{at}ibgm.uva.es
| Introduction |
|---|
|
|
|---|
150 mmHg produced a very strong and short latency (
1 min) catecholamine (CA) release response from chemoreceptor cells of identical magnitude to that obtained while perfusing with N2-equilibrated solutions (Pardal & Lopez-Barneo, 2002) and potentiated hypoxic responses; moreover it was found that low glucose inhibited K+ currents (Pardal & Lopez-Barneo, 2002) in magnitudes that are comparable to those observed by Peers (1990) during intense hypoxia, and promoted Ca2+ entry in chemoreceptor cells (Pardal & Barneo, 2002). More recently, Zhang et al. (2007) working also at PO2 close to 150 mmHg found in cocultures of CB chemoreceptor cells and petrosal ganglion neurons that low glucose increased the spiking activity in the neurons, this increase being sensitive to purinergic (suramin) and nicotinic (mecamylamine) blockers implying that low glucose has stimulated chemoreceptor cells and promoted the release of ATP and acetylcholine. In contrast, Bin-Jaliah et al. (2004) using a freshly isolated rat CB–CSN preparation observed that lowering the glucose concentration from 10 to 2 mM did not alter the activity in the CSN; lowering the glucose further to 0 mM was equally ineffective to alter the output of the CB–CSN. In an additional study of the same group (Bin-Jaliah et al. 2005) it was observed that baseline chemoreceptor discharge obtained at 400 mmHg PO2, 40 mmHg PCO2 and 10 mM glucose was not altered by reducing the glucose to 2 or 0 mM, and additionally it was found that glucose concentration diminution blunted (low glucose) and nearly eliminated (0 glucose) the effect of hypercapnia upon chemoafferent discharge; these authors also observed that prolonging the superfusion to 20 min with 0 glucose in most cases led slowly to reversible decreases or even abolition of the CSN discharge. Thus, the findings obtained in the rat by Bin-Jaliah et al. (2004, 2005) are nearly identical to those reported by Almaraz et al. (1984).
We, as well as Zhang et al. (2007), have noticed that the authors who have found that the CB is not responsive to low glucose have used intact preparations and hyperoxia (Almaraz et al. 1984; Bin-Jaliah et al. 2004, 2005), while the authors who have found that low glucose is a stimulus to chemoreceptor cells (Pardal & Barneo, 2002; Zhang et al. 2007) have used preparations superfused with normoxic or hypoxic solutions. Then, the question arises of whether or not the lack of responsiveness of the intact CB preparation to low glucose is the result of the hyperoxic conditions. To define if the intact carotid body is responsive to low glucose we have measured responses specific to chemoreceptor cells (release of catecholamine and ATP) and recorded electrical activity in the carotid sinus nerve while perfusing with normoxic and hypoxic solutions containing different glucose concentrations. We have tested the effect of lowering the glucose concentration from the control (5.55 mM) to 3, 1 and 0 mM at basal PO2 of about 133 mmHg (superfusion with 20% O2, 5% CO2; balance N2; barometric pressure in Valladolid oscillates around 710 mmHg), mild hypoxia of 66 mmHg (superfusion with 10% O2, 5% CO2; balance N2) and moderate hypoxia of 46 mmHg (superfusion with 7% O2, 5% CO2; balance N2) on the release of CA from chemoreceptor cells. We also tested the effect of 1 mM glucose on the basal as well as on moderately intense hypoxic (PO2
33 mmHg) CSN activity. The effect of prolonged superfusion with 0 mM glucose on the basal CA release and CSN activity was also studied. Lastly, in another group of experiments we compared the release of ATP from the CB in response to 0 mM glucose and a hypoxia of 33 mmHg of PO2. Glucose reduction or deprivation did not have an effect on any response when applied for short periods of time (< 15 min), but if applied for longer periods of time (up to 120 min) it caused a spontaneous increase in basal release that started to appear after 40 min of glucose deprivation, and some bursts of CSN activity with a comparable time course that culminated in a complete loss of the capacity of the CSN to respond to hypoxia. We conclude that the CB chemoreceptor cells in the intact organ are not glucose sensors and that the CB drive to respiration is not altered by short-term hypoglycaemia.
| Methods |
|---|
|
|
|---|
Experiments were performed in adult Wistar rats of both sexes (250–350 g) obtained from the vivarium of the Faculty of Medicine of the University of Valladolid. The Institutional Committee of the University of Valladolid for Animal Care and Use approved the protocols. Rats were anaesthetized with sodium pentobarbital (60 mg kg–1 I.P.) and tracheostomized, the carotid arteries were dissected, and a block of tissue including the carotid sinus area was removed and placed in a Lucite chamber.
For the release of CA and ATP experiments (5–12 CBs/experiment) the CBs were cleaned free of CSN and nearby connective tissue following procedures previously described (Vicario et al. 2000; Conde et al. 2006). For the recording of CSN activity, the CB–CSN preparation was identified under a dissecting microscope and a block of tissue, including the carotid bifurcation and the glossopharyngeal nerve, was removed and placed in a Lucite chamber in ice-cold, 100% O2-equilibrated Tyrode solution (mM: NaCl 140, KCl 5, CaCl2 2, MgCl2 1.1, Hepes 10, glucose 5.5, pH 7.40) for further dissection of tissue surrounding CB and CSN. The CB–CSN preparation was digested during 3–5 min in collagenase type I (1 mg ml–1) solution to loosen the perineurium (Rigual et al. 2002). Thereafter the CB–CSN preparation was transferred to the recording chamber. In all instances animals were killed by intracardiac overdoses of sodium pentobarbital until the beating of the heart ceased.
Labelling of catecholamine stores: release of [3H]CA
CA stores of the chemoreceptor cells were labelled by incubating the CBs for 2 h in Tyrode solution containing the natural precursor [3H]tyrosine (30 µM) (specific activity of 45 Ci mmol–1), and 6-methyl-tetrahydropterine (100 µM) and ascorbic acid (1 mM), cofactors of tyrosine hydroxylase and dopamine-β-hydroxylase, respectively (Fidone & Gonzalez, 1982). After the labelling period, individual CBs were transferred to vials containing 4 ml of precursor-free Tyrode–bicarbonate solution (composition as above except for the replacement of 24 mM of NaCl by 24 mM of NaHCO3). Solutions were continuously bubbled with 20% O2–5% CO2–75% N2 saturated with water vapour, except when hypoxic stimuli were applied. The solutions of the initial incubation periods (3 x 20 min) were discarded to wash out the precursor and the readily releasable pool of labelled CA and thereafter renewed at fixed times (every 2–10 min; see Results) and collected for subsequent analysis of their [3H]CA content. Specific stimulus protocols are provided in Results. Stimuli included hypoxias of two intensities (10 and 7% O2-equilibrated solutions) and low glucose of three concentrations (0, 1 and 3 mM of glucose) and were applied either separately or in combination (see Results). Collected solutions were acidified with glacial acetic acid to pH 3 and maintained at 4°C until analysis to prevent [3H]CA degradation. [3H]CAs present in the incubating solutions were analysed as previously described by Vicario et al. (2000) and Conde et al. (2006), in brief, by adsorption onto alumina at alkaline pH (pH 8.6), bulk elution of tritiated catechols with hydrochloric acid (1 N) and quantification by scintillation counting. CBs were homogenized (glass to glass; 4°C) in 200 µl of 0.6 M perchloric acid and centrifuged for 10 min (4°C; 12000 g) in a microfuge (Beckmann, Madrid). Tissue supernatants were analysed for their [3H]catechol content as described above for the incubating solutions. Previous HPLC analyses have shown that over 90% of the [3H]catechols present in the alumina eluates correspond to [3H]dopamine (DA) and its catabolite 3,4-[3H]dihydroxyphenylacetic acid (DOPAC) (Vicario et al. 2000). [3H]CA release data are expressed as a percentage of tissue content, i.e. dpm present in each collected incubating solution divided by dpm present in tissue supernatant multiplied by 100, or as dpm present in each collected incubating solution.
Endogenous release of ATP from carotid body
The CBs were incubated in 500 µl of Tyrode–bicarbonate solution. The incubating solutions were maintained at 37°C and continuously bubbled with 20% O2–5% CO2–75% N2 except when the hypoxic stimuli were applied; in all instance the gas mixtures were saturated with water vapour. The solution of the initial incubation period (1 x 15 min) was discarded. After, the solutions were renewed every 10 min and collected. The stimuli include: between minute 25 and 35, incubation with low glucose (0 mM glucose), and between minute 55 and 65, intense hypoxia (33 mmHg of PO2). The collected fractions were acidified with 300 µl of 3 M PCA. At the end of the experiment, the CBs were immersed in 100 µl of 3 M PCA and weighed. The collected fractions were maintained for 10 min at 0°C and then centrifuged 12 000 g for 10 min (4°C). ATP was extracted from the supernatant as described by Cunha et al. (1994). ATP release was quantified by a bioluminescence luciferin–luciferase assay. Briefly, for ATP quantification 100 µl of the samples was added to 100 µl of luciferin–luciferase (FLE50, Sigma) and to 2 ml of buffer (mM: Hepes 20, MgCl2 25, Na2HPO4 5). The reaction begins when the enzyme is added to the mixture. The samples were analysed in triplicate during 1 min by bioluminescence using a luminescence counter (Beckham). Quantification of endogenous ATP released by CB was done against external standards.
Recording of CSN activity
The CB–CSN preparation was transferred to a recording chamber mounted on a dissection microscope (Nikon Corporation, Tokyo, Japan) and superfused (37°C) with bicarbonate/CO2 buffered Tyrode solution (mM: NaCl 120, NaHCO3 24, KCl 3, CaCl2 2, MgCl2 1.1, glucose 5, pH 7.40). Recordings of single or few fibres of CSN were made using a suction electrode. The pipette potential was amplified (NeuroLog, Digitimer, Welwyn Garden City, UK), displayed on an oscilloscope and stored in a PC (200 Hz acquisition rate, Axonscope, Axon Instruments, Union City, CA, USA). Chemoreceptor activity was identified (spontaneous generation of action potentials at irregular intervals) and confirmed by its increase in response to hypoxia (normoxia: 20% O2, 5% CO2; balance N2; hypoxia: 0% O2, 5% CO2; balance N2). CSN activity was digitalized, summed every second and converted in a voltage proportional to the sum. The effects of low glucose (1 mM of glucose) on the control and hypoxic CSN activity were studied while perfusing the preparations with normoxic (20% O2-equilibrated) and hypoxic (5% O2-equilibrated) solutions; both responses were obtained from the same CB and 1 mM of glucose was present in the superfusing solution 5 min prior to stimulus application (20% O2-equilibrated solutions) and the 3 min of hypoxic stimulation.
Data analysis
Data were evaluated using GraphPad Prism v. 4 (GraphPad Software Inc., San Diego, CA, USA) and are presented as means ± S.E.M. The significance of the differences between the means was calculated by unpaired Student's t test and by one- and two-way analysis of variance (ANOVA) with Dunnett's and Bonferroni's multiple comparison tests, respectively. P values of 0.05 or less were considered to represent significant differences.
| Results |
|---|
|
|
|---|
Figure 1A
shows three single experiments carried out with individual CBs in normoxic conditions (20% O2-equilibrated solutions; PO2
133 mmHg). Control CB was continuously superfused with a solution containing 5.5 mM glucose. Experimental CBs were similarly superfused with a solution containing 5.5 mM glucose except for the periods indicated. In one of the experimental CBs, we tested sequentially decreasing (0, 1 and 3 mM), and in the other increasing levels of hypoglycaemia (3, 1 and 0 mM) as potential stimuli for the CB. The ascending and descending patterns of low glucose application were aimed to avoid potential processes of sensitization or desensitization of the responses that might blur or mask the genuine effect of low glucose. As can be observed in Fig. 1C the mean basal (normoxic) release of [3H]CA from the CB was not modified by the graded reduction of glucose (3, 1 and 0 mM) maintaining the standard monotonic slow decay observed in control CB (Fig. 1B; see Almaraz et al. 1986 and Conde et al. 2006). In the same manner, the graded increase of glucose levels (0, 1 and 3 mM) did not modify the mean basal release of [3H]CA from the rat CB (Fig. 1D).
|
66 mmHg applied during the entire experiment). Incubating solutions for control CB contained 5.5 mM glucose for the entire experiment. For the experimental CBs, incubating solutions also contained 5.5 mM glucose except for the indicated 10 min periods; in one of the experimental CB the incubating solution contained 0, 1 and 3 mM glucose, respectively, for minutes 20–30, 50–60 and 80–90 of the experiment, while in the other experimental CB an increasing level of hypoglycaemia (3, 1 and 0 mM glucose) was tested at the same intervals of the experiment. It can be observed that glucose does not modify the release of [3H]CA evoked by mild hypoxia. Notice also that the same monotonic decay of the CA release, but with a higher CA output, was observed at 66 (Fig. 2A) and at 133 (Fig. 2A) mmHg of PO2. Figure 2B–D shows mean time courses of the mild hypoxic release in control conditions (5.5 mM glucose) and with intercalated episodes of hypoglycaemia. It can be observed that none of the low glucose levels tested modified (inhibited or potentiated) the time course for the [3H]CA evoked by mild hypoxia.
|
|
Recently it was published by Zhang et al. (2007) that low glucose stimulates ATP secretion in fresh tissue slices of rat CB, suggesting that low glucose utilizes similar neurotransmitter and neuromodulatory mechanisms to hypoxia. Since our data on the effect of low glucose on the release of CA are the opposite of previously published findings (Pardal & Barneo, 2002), we also wanted to investigate if low glucose modifies the release of ATP from the intact rat CB. As can be observed in Fig. 4 , incubation of CB with a solution without glucose (0 mM) did not alter the ATP levels released from whole rat CB (98.04 ± 11.04 pmol (mg tissue)–1, n = 5) when compared with basal values (105.5 ± 7.54 pmol (mg tissue)–1, n = 5). In order to check the CB functionality, we tested in the same experiments the effect of hypoxia (5% O2) on the release of ATP and we observed that this stimulus increased by 122.1% the release of ATP from whole rat CB (Fig. 4), from 76.98 ± 7.83 pmol (mg tissue)–1 (ATP release from minutes 45–55 of the experiment; n = 5) to 170.6 ± 34.11 pmol (mg tissue)–1 (ATP release from minutes 55–65 of the experiment n = 5) (P = 0.008). Since the total ATP content in the CBs is in the vicinity of 4 nmol (mg tissue)–1, the fractional release of ATP in normoxia (ATP release x 10 min–1/ATP tissue content) amounts to 1.98%/10 min (Conde & Monteiro, 2006).
|
The direct effect of low glucose on the output of the CB was tested on the in vitro CB–CSN preparation by monitoring the action potential frequency in the CSN. In Fig. 5A a single experiment is presented. The preparation was initially superfused with solutions containing 5.5 mM glucose, and after a period of recording in normoxic conditions (superfusion with 20% O2-equilibrated solution) a hypoxic stimulus was applied (3 min superfuson with solutions equilibrated with 5% O2). The superfusion with normoxic normoglycaemic solution continued for 10 min and thereafter we started a superfusion with normoxic hypoglycaemic (1 mM glucose) that lasted 5 min followed by a 3 min hypoxic test while maintaining hypoglycaemia. To facilitate the comparison of the responses the records are superimposed, and at the top of the figure sample neurograms are shown. Reduction of glucose in the superfusion from 5.55 mM to 1 mM did not modify the basal normoxic activity of CSN (Fig. 5A and B) (5.55 mM glucose: 3.133 ± 3.6 Hz versus 1 mM glucose: 2.70 ± 0.4 Hz; P = 0.455), nor the frequency of discharges evoked by hypoxia in the CSN (Fig. 5C): 53.81 ± 7.8 (5% O2 + 5.55 mM glucose, n = 7) versus 52.69 ± 9.1 (5% O2 + 1 mM glucose, n = 7) (P = 0.93). Superfusion with 1 mM glucose delayed significantly the onset of the hypoxic response (latency of the response) (P < 0.05, two-way ANOVA with Bonferroni's multicomparison test) but not the time to reach the maximal activity (time to peak) (Fig. 5D).
|
We also searched for the effects of longer applications (100 and 120 min) of 0 mM glucose on the basal release of [3H]CA from CB chemoreceptor cells and CSN chemosensory activity. Figure 6 shows that low glucose did not alter basal [3H]CA release for the initial 40 min (minutes 30–70 of the experiment). Thereafter, the release of the [3H]CA started to increase and continued to increase until the end of the experiment. Contrary to that, the release from control CBs exhibited the normal monotonic decay usually observed (see also Figs 1 and 2). In the same manner, and as previously observed by Almaraz et al. (1984) in the cat, long-term superfusion with 0 glucose did not modify the spontaneous normoxic CSN chemosensory activity in the rat in the first hour of application, but prolonging the 0 glucose superfusion to 100 min resulted in a decrease in the spontaneous CSN activity and a loss of capacity to respond to hypoxia (data not shown; see Almaraz et al. 1984).
|
| Discussion |
|---|
|
|
|---|
The present results confirm previous findings from our laboratory using the intact cat CB–CSN preparation (Almaraz et al. 1984). It should be stated that those old experiments were beyond the scope of the present study, and on no occasion did we detect an activation of CSN discharges. The present findings also confirm those recently reported by Bin-Jaliah et al. (2004, 2005) in the freshly isolated rat CB–CSN preparation: low and 0 glucose do not activate the arterial chemoreceptors. As mentioned in the Introduction, the studies just mentioned used preparations superfused with solutions equilibrated at PO2 > 400 mmHg. Although, conceptually, probably high PO2 represents the ideal conditions to test for the ability of the CB to sense any given stimulus (different from hypoxia itself), the fact that Pardal & Lopez-Barneo (2002; see also Zhang et al. 2007) described sensitivity of chemoreceptor cells to low glucose at near physiological PO2 prompted the study at different PO2. As shown throughout our study, at none PO2 tested (
133, 66, 46 and 33 mmHg) did low glucose or zero glucose activates either chemoreceptor cells or the CB–CSN complex. Thus, differences in the PO2 used in the experiments in intact preparations versus slices or cocultures is not the factor determining divergent findings as suggested by Zhang et al. (2007) as we originally thought in designing the study.
We do not have a satisfactory explanation for the discrepancies in findings, but it might be that differences in preparations can be responsible for them. For example, Pardal & Lopez-Barneo (2002) used rat CB slices (the intact rat CB weighs as an average 50 µg, i.e. if considered spherical it will be less than 250 µm in diameter) cultured for 48–72 h and therefore the possibility exists that either the preparation of the slices itself (temperature shock, attachment with cyanoacrylate of the blocks) or the culture conditions modifies the phenotype of chemoreceptor cells. These considerations hold also for part of the study of Zhang et al. (2007). In fact several studies support our contentions. For example, Gauda (2002) and Gauda et al. (2004) in semiquantitative in situ hybridization histochemistry and immunohistochemistry did not detect cholinergic traits in chemoreceptor cells, traits that were patent in microganglion cells and nerve fibres innervating the rat CB; on the contray, Zhang et al. (2000) provided evidences for cholinergic markers in chemoreceptor cells in their chemoreceptor cell–petrosal ganglion neuron cocultures. The recent studies of Reyes et al. (2007a,b), although performed in different species, point in the same direction: these authors found in in vivo and in vitro preparations that a combination of nicotinic and purinergic blockers only partially reduced the activity elicited by hypoxia in the CSN or reflexly in the phrenic nerve in cat preparations; Zhang et al. (2000) in their coculture preparation found that the same mixture of blockers completely abrogates the hypoxic responses. Recent data of He et al. (2005, 2006) obtained in the intact rat CB–CSN preparation would also be consistent with the observations of Reyes et al. (2007a,b).
More intriguing are the findings on the release of ATP by Zhang et al. (2007); in slices prepared and studied in the course of 1 h, i.e. when the phenotypic changes are unlikely to have appeared, they found that hypoglycaemia promotes the release of ATP from CB slices. However, we are puzzled by the data of these authors on the release of ATP. In a previous publication of the same laboratory there was reported a release of ATP from CB slices that was extremely high (Buttigieg & Nurse, 2004), and in the more recent publication (Zhang et al. 2007) they also report amounts of ATP released that still appear very high if they are compared with data obtained in bovine chromaffin cells stimulated with nicotine (Kuijpers et al. 1989) and in hippocampal synaptosomes (Cunha et al. 2000). In these two last preparations, as well as in the intact CB (present study), the ATP release per 3 min approaches 0.6% of the tissue content, nearly 15 times lower than the release obtained in the slice preparation by Zhang et al. (2007).
In any case it should be mentioned that there are also discrepancies between the findings of Pardal & Lopez-Barneo (2002) and those of Zhang et al. (2007). The first authors found that input resistance measured in patch-clamped cells (–80 mV) was not altered by removal of glucose; on the contrary, glucose deficiency produced a reversible reduction of outward K+ current amplitude in the entire range of membrane potentials (–40 to +60 mV) implying that chemoreceptor cell depolarization and Ca2+ entry was associated with an increase in cell input resistance (see Kumar, 2007). On the contrary, Zhang et al. (2007) found that hypoglycaemia produced chemoreceptor cell depolarization, which was associated with a decrease in input resistance in the cell. A very recent publication of Lopez-Barneo's laboratory (Garcia-Fernandez et al. 2007) using the same slice preparation as the previous study (Pardal & Lopez-Barneo, 2002) confirms most of their previous observations. However, contrary to previous findings, they report now that low glucose induces a transient receptor potential channel-mediated inward current (i.e. a decrease in input resistance) that would be responsible for cell depolarization and triggering of the CA release response. In the most recent publication (Garcia-Fernandez et al. 2007) they also observed that inhibition of K+ currents with TEA or iberiotoxin elicits a minimal secretory response while in a previous publication (Pardal et al. 2000), using the same slice preparation, they reported that TEA and iberiotoxin elicited a powerful secretory response that nearly doubled that elicited by intense hypoxia, which in turn was comparable to that elicited by 0 glucose (Pardal & Lopez-Barneo, 2002).
In conclusion, the present data do not support the role of chemoreceptor cells as glucose sensors, and certainly do not confirm the notion that the CB forms part of a group of extracranial glucose sensors like pancreas, liver and hepatic portal vein, thereby, initiating reflex responses when the levels of glucose fall below the normal range. On the contrary, our data fit the notions advanced by Bin-Jaliah et al. (2004) indicating that the carotid body-dependent increase in ventilation observed in hypoglycaemia, for example in hypoglycaemia induced by insulin injection, would be produced through the increased systemic metabolic rate and modifications in arterial blood gas tensions produced by insulin, and not by hypoglycaemia per se.
| References |
|---|
|
|
|---|
Almaraz L, Obeso A & Gonzalez C (1984). Metabolic dissociation of carotid body chemoreceptors responses to different types of stimulation: preliminary findings. In The Peripheral Arterial Chemoreceptors, ed. Pallot DJ, pp. 141–151. Oxford University Press, New York.
Alvarez-Buylla R & Alvarez-Buylla ER (1988). Carotid sinus receptors participate in glucose homeostasis. Respir Physiol 723, 347–359.
Bin-Jaliah I, Maskell PD & Kumar P (2004). Indirect sensing of insulin-induced hypoglycaemia by the carotid body in the rat. J Physol 556, 225–266.
Bin-Jaliah I, Maskell PD & Kumar P (2005). Carbon dioxide sensitivity during hypoglycaemia-induced, elevated metabolism in the anaesthetized rat. J Physiol 563, 883–893.
Buttigieg J & Nurse CA (2004). Detection of hypoxia-evoked ATP release from chemoreceptor cells of the rat carotid body. Biochem Biophy Res Com 322, 82–87.[CrossRef]
Conde SV & Monteiro EC (2006). Profiles for ATP and adenosine release at the rat carotid body in response to O2 concentrations. Adv Exp Med Biol 580, 179–184.[Medline]
Conde SV, Obeso A, Vicario I, Rigual R, Rocher R & Gonzalez C (2006). Caffeine inhibition of rat carotid body chemoreceptors is mediated by A2A and A2B adenosine receptors. J Neurochem 98, 616–628.[CrossRef][Medline]
Cunha RA, Almeida T & Ribeiro JA (2000). Modification by arachidonic acid of extracellular adenosine metabolism and neuromodulatory action in the rat hippocampus. J Biol Chem 275, 37572–37581.
Cunha RA, Milusheva E, Vizi ES, Ribeiro JA & Sebastião AM (1994). Excitatory and inhibitory effects of A1 and A2 adenosine receptor activation on the electrically evoked [3H]acetylcholine release from different areas of the rat hippocampus. J Neurochem 63, 207–214.[Medline]
Fidone SJ & Gonzalez C (1982). Catecholamine synthesis in rabbit carotid body in vitro. J Physiol 333, 69–79.
Garcia-Fernandez M, Ortega-Saenz P, Castellano A & Lopez-Barneo J (2007). Mechanisms of low-glucose sensitivity in carotid body glomus cells. Diabetes (in press).
Gauda EB (2002). Gene expression in peripheral arterial chemoreceptors. Micro Res Tech 59, 153–167.[CrossRef]
Gauda EB, Cooper R, Johnson SM, McLemore GL & Marshall C (2004). Autonomic microganglion cells: a source of acetylcholine in the rat carotid body. J Appl Physiol 96, 384–391.
Gonzalez C, Almaraz L, Obeso A & Rigual R (1994). Carotid body chemoreceptors: from natural stimuli to sensory discharges. Physiol Rev 74, 829–898.
He L, Chen J, Dinger B, Stensaas L & Fidone S (2006). Effect of chronic hypoxia on purinergic synaptic transmission in rat carotid body. J Appl Physiol 100, 157–162.
He L, Dinger B & Fidone S (2005). Effect of chronic hypoxia on cholinergic chemotransmission in rat carotid body. J Appl Physiol 98, 614–619.
Koyama Y, Coker RH, Stone EE, Lacy DB, Jabbour K, Williams PE & Wasserman DH (2000). Evidence that carotid bodies play an important role in glucoregulation in vivo. Diabetes 49, 1434–1442.[Abstract]
Kuijpers GA, Rosario LM & Ornberg RL (1989). Role of intracellular pH in secretion from adrenal medulla chromaffin cells. J Biol Chem 264, 698–705.
Kumar P (2007). How sweet it is: sensing low glucose in the carotid body. J Physiol 578, 627.
Pardal R & Lopez-Barneo L (2002). Low glucose-sensing cells in the carotid body. Nat Neurosci 5, 197–198.[CrossRef][Medline]
Pardal R, Ludewig U, Garcia-Hirschfeld J & Lopez-Barneo J (2000). Secretory responses of intact glomus cells in thin slices of rat carotid body to hypoxia and tetraethylammonium. Proc Natl Acad Sci U S A 97, 2361–2366.
Peers C (1990). Hypoxic suppression of K+ currents in type I carotid body cells: selective effect on the Ca2+-activated K+ current. Neurosci Lett 119, 253–256.[CrossRef][Medline]
Reyes EP, Fernandez R, Larrain C & Zapata P (2007a). Effects of combined cholinergic-purinergic block upon cat carotid body chemoreceptors in vitro. Respir Physiol Neurobiol 156, 17–22.[CrossRef][Medline]
Reyes EP, Fernandez R, Larrain C & Zapata P (2007b). Carotid body chemosensory activity and ventilatory chemoreflexes in cats persist after combined cholinergic-purinergic block. Respir Physiol Neurobiol 156, 23–32.[CrossRef][Medline]
Rigual R, Rico AJ, Prieto-Lloret J, de Felipe C & Gonzalez C (2002). Chemoreceptor activity is normal in mice lacking the NK1 receptor. Eur J Neurosci 16, 2078–2084.[CrossRef][Medline]
Vicario I, Rigual R, Obeso A & Gonzalez C (2000). Characterization of the synthesis and release of catecholamine in the rat carotid body in vitro. Am J Physiol Cell Physiol 278, C490–C499.
Zhang M, Buttigieg J & Nurse C (2007). Neurotransmitter mechanisms mediating low-glucose signalling in co-cultures and fresh tissue slices of rat carotid body. J Physiol 578, 735–750.
Zhang M, Zhong H, Vollmer C & Nurse CA (2000). Co-release of ATP and ACh mediates hypoxic signaling at rat carotid body chemoreceptors. J Physiol 525, 143–158.
| Acknowledgements |
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |